# Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

> **NCT01415531** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 641 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01415531
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 641 (ACTUAL)
- **Last updated:** 2013-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01415531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01415531, "Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01415531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*